296 related articles for article (PubMed ID: 11950687)
21. APC resistance: biological basis and acquired influences.
Castoldi E; Rosing J
J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
[TBL] [Abstract][Full Text] [Related]
22. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
Thomassen MC; Castoldi E; Tans G; Magdeleyns EJ; Delaunoit C; Debusscher L; Van Assche KJ; Rosing J
Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
[TBL] [Abstract][Full Text] [Related]
23. Factor V and protein S as cofactors to activated protein C.
Dahlbäck B
Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
[TBL] [Abstract][Full Text] [Related]
24. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Norstrøm E; Thorelli E; Dahlbäck B
Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
[TBL] [Abstract][Full Text] [Related]
26. Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.
Shimonishi N; Ogiwara K; Yoshida J; Horie K; Nakajima Y; Furukawa S; Takeyama M; Nogami K
Blood Adv; 2023 Jun; 7(12):2831-2842. PubMed ID: 36780344
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
[TBL] [Abstract][Full Text] [Related]
28. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
[TBL] [Abstract][Full Text] [Related]
29. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
30. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
31. Congenital and acquired activated protein C resistance.
Nicolaes GA; Dahlbäck B
Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
[TBL] [Abstract][Full Text] [Related]
32. Peptidomimetic inhibitors for activated protein C: implications for hemophilia management.
Butenas S; Orfeo T; Kalafatis M; Mann KG
J Thromb Haemost; 2006 Nov; 4(11):2411-6. PubMed ID: 17059471
[TBL] [Abstract][Full Text] [Related]
33. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
Wiencek JR; Na M; Hirbawi J; Kalafatis M
J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
[TBL] [Abstract][Full Text] [Related]
34. Factor V: Dr. Jeckyll and Mr. Hyde.
Kalafatis M; Mann KG
Adv Exp Med Biol; 2001; 489():31-43. PubMed ID: 11554589
[TBL] [Abstract][Full Text] [Related]
35. Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
Petrillo T; Ayombil F; Van't Veer C; Camire RM
J Biol Chem; 2021; 296():100234. PubMed ID: 33376137
[TBL] [Abstract][Full Text] [Related]
36. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
Tran S; Norstrøm E; Dahlbäck B
J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180
[TBL] [Abstract][Full Text] [Related]
37. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Villoutreix BO; Dahlbäck B
Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
[TBL] [Abstract][Full Text] [Related]
38. Early days of APC resistance and FV Leiden.
Dahlbäck B
Hamostaseologie; 2008; 28(3):103-9. PubMed ID: 18521487
[TBL] [Abstract][Full Text] [Related]
39. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
Schuijt TJ; Bakhtiari K; Daffre S; Deponte K; Wielders SJ; Marquart JA; Hovius JW; van der Poll T; Fikrig E; Bunce MW; Camire RM; Nicolaes GA; Meijers JC; van 't Veer C
Circulation; 2013 Jul; 128(3):254-66. PubMed ID: 23817575
[TBL] [Abstract][Full Text] [Related]
40. The anticoagulant function of coagulation factor V.
Cramer TJ; Gale AJ
Thromb Haemost; 2012 Jan; 107(1):15-21. PubMed ID: 22116556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]